Title:
6-ピリミジニル-ピリミド-4-オン誘導体
Document Type and Number:
Japanese Patent JP2010538969
Kind Code:
A
Abstract:
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).
More Like This:
| JP2020505399 | Compound |
| JP4368375 | Piperidine-benzenesulfonamide derivative |
| WO/2002/002525 | N-UREIDOHETEROCYCLOAKLYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY |
Inventors:
Kenji Fukunaga
Kazutoshi Watanabe
Berneu Pascal
Benavides Jesus
Pratt Jeremy
Kazutoshi Watanabe
Berneu Pascal
Benavides Jesus
Pratt Jeremy
Application Number:
JP2010510582A
Publication Date:
December 16, 2010
Filing Date:
September 12, 2008
Export Citation:
Assignee:
Mitsubishi Tanabe Pharma Corporation
Sanofi-Aventis
Sanofi-Aventis
International Classes:
C07D413/14; A61K31/5377; A61P3/04; A61P3/10; A61P9/10; A61P17/14; A61P19/10; A61P25/00; A61P25/16; A61P25/18; A61P25/28; A61P27/02; A61P27/06; A61P33/06; A61P35/00; A61P35/02; A61P43/00
Domestic Patent References:
| JP2005510472A | 2005-04-21 |
Attorney, Agent or Firm:
Patent Service Corporation Patent Office Sykes